Roivant Sciences' lupus drug fails to reduce symptoms in mid-stage study
Roivant Sciences said on Monday its experimental drug to treat autoimmune disease systemic lupus erythematosus failed to meet the main goal of reducing symptoms in a mid-stage study. ...